Incyte plans to acquire early-stage company focused on vitiligo skin disease

Delaware Business Now

Oct 3, 2022

Incyte entered into an agreement to acquire Villaris Therapeutics a start-up focused on the development of novel antibody therapeutics for the skin disease vitiligo. The disease le…